Back to News
Market Impact: 0.15
ImmunoScape Appoints Peter Olagunju as Chief Executive Officer
Source: Business Wire
Healthcare & BiotechManagement & Governance
ImmunoScape appointed Peter Olagunju as CEO as it prepares to move its Seed and Boost platform into clinical development. The leadership change supports the biotech company's transition toward a key clinical-stage milestone, though no financial terms, trial timing, or efficacy data were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- Australia says OpenAI agent hacked Medicare portal
- US aviation sanctions disrupt Iran flights, push travellers overland
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- OpenAI agents ‘infiltrated Australian government website’
- Activist Toms Capital urges Devon Energy in letter to explore alternatives, including a sale